Clinical trial
An Observational Study on the Efficacy and Safety of the Combination Regimen Based on Eravacycline in the Treatment of Multidrug-resistant Bacterial Infections in Immunocompromised Host Populations.
NCT06223100 is registered in ClinicalTrials.gov with Sichuan Provincial People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Study on the Efficacy and Safety of the Combination Regimen Based on Eravacycline in the Treatment of Multidrug-resistant Bacterial Infections in Immunocompromised Host Populations.
- Lead sponsor
- Sichuan Provincial People's Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- February 1, 2024
- Completion date
- December 31, 2025
- Enrollment
- 100 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
immune dysregulation disorder